Linköping, Sweden [February 12, 2018] AMRA has today announced its further commitment to global expansion..
12 February 2018
AMRA is an international digital health company and the first in the world to transform images from a rapid, 6-minute whole body MRI scan into precise, 3D-volumetric fat and muscle measurements.
We are confronting global health challenges by enhancing the evidence base needed to predict and prevent disease.
AMRA® Profiler Research enables regional and complete segmentation and quantification of muscle and fat tissue volumes in the body.
"AMRA-derived body composition data enables us at Human Longevity Inc to integrate quantitative imaging results with genomic and clinical biomarkers to give our clients and their physicians a comprehensive evaluation of their risk for diabetes, cardiovascular disease and metabolic syndrome."
David S. Karow, Human Longevity, Inc.
"I am very impressed with the body composition analysis that AMRA offers. The system works well and we get valuable data in a fast way. I am very pleased with the extra opportunities this will provide us to further improve our scientific research. The people are great to work with and there is fast, good service"
Cas Fuchs, Maastricht University
Global healthcare systems are facing unprecedented challenges associated with a rapid rise in obesity, metabolic-related disease, and an aging population. AMRA is confronting these challenges by supporting medical leaders with the knowledge and evidence-base needed to predict and prevent diseases.